The pathogenic role and impact of SRPX2 in GBM (Tang et al., 2016) is less well characterised, despite been well studied in cancer (Hong et al., 2018; Tanaka et al., 2009; Lin et al., 2017; Zhang et al., 2018). The gene discussed is SRPX2; the disease is glioblastoma.